HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Joseph A Cornicelli Selected Research

gemcabene

12/2018Gemcabene, a first-in-class lipid-lowering agent in late-stage development, down-regulates acute-phase C-reactive protein via C/EBP-δ-mediated transcriptional mechanism.
1/2018Gemcabene, a First-in-Class Hypolipidemic Small Molecule in Clinical Development, Attenuates Osteoarthritis and Pain in Animal Models of Arthritis and Pain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Joseph A Cornicelli Research Topics

Disease

3Arthritis (Polyarthritis)
01/2018 - 07/2012
2Atherosclerosis
12/2018 - 08/2002
2Inflammation (Inflammations)
12/2018 - 01/2018
2Rheumatoid Arthritis
11/2012 - 07/2012
1Hepatocellular Carcinoma (Hepatoma)
12/2018
1Hyperalgesia
01/2018
1Osteoarthritis
01/2018
1Pain (Aches)
01/2018
1Experimental Arthritis
07/2012

Drug/Important Bio-Agent (IBA)

3CollagenIBA
01/2018 - 07/2012
2gemcabeneIBA
12/2018 - 01/2018
2TCH-013IBA
11/2012 - 07/2012
2CytokinesIBA
11/2012 - 07/2012
2ImidazolinesIBA
11/2012 - 07/2012
1C-Reactive ProteinIBA
12/2018
1Interleukin-6 (Interleukin 6)IBA
12/2018
1Monoclonal AntibodiesIBA
01/2018
1CarrageenanIBA
01/2018
1Iodoacetic AcidIBA
01/2018
1Class A Scavenger ReceptorsIBA
08/2002
1CholesterolIBA
08/2002
1LDL Receptors (LDL Receptor)IBA
08/2002